The purpose of this post is simple. I want to explain why the Toronto Maple Leafs don’t just need one high-level front-office ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing ...

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI); ("Scinai" or the "Company"), a biopharmaceutical company developing inflammation ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of ...

Liquid biopsy technologies, particularly circulating tumor DNA, or ctDNA, are changing how clinicians monitor hematologic ...

Department of NGO International Affairs Director Chiang Zhen-wei (江振瑋), director-general of the ministry’s drone diplomacy ...

Completed End-of-Phase 2 meeting with the FDA; Company expects to provide a regulatory update in early 2Q 2026 and remains on track to initiate a Phase 3 study in chronic tetraplegia in mid-2026.

Magicbricks partners with School of Planning and Architecture Delhi to combine real estate data with urban planning research, ...

Professor of Accounting at Lead City University, Godwin Oyedokun, has explained that a successful conclusion of the Central ...

Nevada researchers are developing a robotic watering system and a facial-recognition AI model to identify and capture data on ...

The OSCE Mission in Kosovo has released two complementary publications: the Advocacy Brief "From Intent to Impact - ...

Daimler Truck, the Volvo Group, cellcentric and Toyota Motor Corporation have signed a non-binding Memorandum of Understanding to collaborate on fuel ...